Oncologix Tech Inc (OCLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
(Values in U.S. thousands)
| 08-1984 | |
| Sales | 1,586 |
| Cost of Goods | 1,041 |
| Gross Profit | 545 |
| Operating Expenses | 555 |
| Operating Income | 32 |
| Interest Expense | 8 |
| Pre-tax Income | 24 |
| Income Tax | 4 |
| Net Income Continuous | 20 |
| Net Income | $20 |
| EPS Basic Total Ops | 3.86 |
| EPS Basic Continuous Ops | 3.86 |
| EPS Diluted Total Ops | 3.86 |
| EPS Diluted Continuous Ops | 3.86 |
| EBITDA(a) | $32 |